Fei Mo
Impact in
- Molecular Biology top 10%
- Epigenetics and DNA Methylation
- Advanced biosensing and bioanalysis techniques
- Histone Deacetylase Inhibitors Research
- RNA modifications and cancer
- Cancer-related gene regulation
- Protein Degradation and Inhibitors
- Cancer Research top 10%
- MicroRNA in disease regulation
Papers in
-
- Advanced biosensing and bioanalysis techniques 11
- Epigenetics and DNA Methylation 6
- RNA Interference and Gene Delivery 5
- Bacterial biofilms and quorum sensing 3
-
- Antifungal resistance and susceptibility 4
- Co-authors
- Yuan Cheng (2 shared papers)Xuelei Ma (2 shared papers)Manni Wang (1 shared paper)He Cai (1 shared paper)Xiawei Wei (2 shared papers)Shengyong Yang (1 shared paper)Junhong Han (1 shared paper)Jian Huang (9 shared papers)
In The Last Decade
Fei Mo
40 papers receiving 1.5k citations
Fei Mo's Hit Papers
Peers
Comparison fields: 5 of 118
- Molecular Biology 1.2k
- Cancer Research 242
- Oncology 160
- Biomedical Engineering 231
- Immunology 107
Countries citing papers authored by Fei Mo
This map shows the geographic impact of Fei Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Mo more than expected).
Fields of papers citing papers by Fei Mo
This network shows the impact of papers produced by Fei Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Mo. The network helps show where Fei Mo may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Mo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials Hit paper breakdown → | 2019 | 735 |
| 2 | 2019 | 120 | |
| 3 | 2017 | 114 | |
| 4 | 2021 | 55 | |
| 5 | 2017 | 54 | |
| 6 | 2018 | 49 | |
| 7 | 2021 | 34 | |
| 8 | 2015 | 27 | |
| 9 | 2020 | 25 | |
| 10 | 2017 | 25 | |
| 11 | 2014 | 22 | |
| 12 | 2021 | 21 | |
| 13 | 2021 | 20 | |
| 14 | 2016 | 20 | |
| 15 | 2018 | 17 | |
| 16 | 2024 | 15 | |
| 17 | 2018 | 15 | |
| 18 | 2016 | 12 | |
| 19 | 2019 | 11 | |
| 20 | 2020 | 11 |
About Fei Mo
Fei Mo is a scholar working on Molecular Biology, Infectious Diseases, Biomedical Engineering, Surgery and Soil Science, having authored 40 papers that have together received 1.5k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (11 papers), Epigenetics and DNA Methylation (6 papers), RNA Interference and Gene Delivery (5 papers), Biosensors and Analytical Detection (5 papers), Antifungal resistance and susceptibility (4 papers), Soil Carbon and Nitrogen Dynamics (4 papers), Bacterial biofilms and quorum sensing (3 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). The work is most often cited by research in Molecular Biology (1.2k citations), Cancer Research (242 citations), Oncology (160 citations), Biomedical Engineering (231 citations) and Immunology (107 citations). Fei Mo has collaborated with scholars based in China, Thailand and Egypt. Frequent co-authors include Yuan Cheng, Xuelei Ma, Manni Wang, He Cai, Xiawei Wei, Shengyong Yang, Junhong Han, Jian Huang, Wei Cheng and Junsong Zheng. Their work appears in journals such as Scientific Reports, Sensors and Actuators B Chemical, Biosensors and Bioelectronics, Phytomedicine and Microchimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.